MCL1 and acute myeloid leukemia: Therefore, the effects of E7820 in hematological malignancies (such as AML) are also being investigated (127).Targeting the inflammatory pathways that lead to MCL-1 overexpression may provide an alternative approach to inhibiting this anti-apoptotic protein in myeloid malignancies.